Celldex Therapeutics (CLDX) Q4 2020 Earnings

5NovConfirmed
Q4 2019
Q2 2020
Q3 2020
Q4 2020
-0.84
-0.68
-0.52
-0.36

Details

Expected EPS
-0.36
Actual EPS
-0.36
Surprise EPS
0
Surprise Percent
+0%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.36 per share for Q4 2020.

0 Comments

Share your thoughts